Skip to content

European Medicines Agency’s (EMA) Committee For Orphan Medicinal Products (COMP) February 2013 Meeting Results

February 13, 2013

EMA’s Committee for Orphan Medicinal Products (COMP) held a meeting February 5 – 6, 2013. The EMA COMP February 2013 Meeting Report on the review of applications for orphan designation is published February 13, 2013. At this meeting, there are 12 positive opinions recommending orphan designation for the treatment of :

  1. Hepatocellular carcinoma
  2. Non-infectious uveitis
  3. Prevention of graft rejection following solid organ transplantation
  4. Sickle cell disease
  5. Niemann-Pick disease, type C
  6. Congenital antitrypsin deficiency
  7. X-linked juvenile retinoschisis
  8. Mantle cell lymphoma
  9. Systemic sclerosis
  10. Churg-Strauss syndrome
  11. Stargardt’s disease
  12. Neuronal ceroid lipofuscinosis type 2.

2013 EMA COMP Calendar

  1. March 12 – 13, 2013
  2. April 16 – 17, 2013
  3. May 14 – 15, 2013
  4. June 11 – 12, 2013
  5. July 9 – 10, 2013
  6. September 3 – 4, 2013
  7. October 8 – 9, 2013
  8. November 5 – 6, 2013
  9. December 10 – 11, 2013.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: